¼¼°èÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ¹× µ¿Çâ(2025-2032³â)
Antibodies Contract Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1689657
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â ¼¼°èÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, Ãß¼¼, ±âȸ ¹× ¾ïÁ¦¿äÀΰú °°Àº Áß¿äÇÑ ½ÃÀå ¿ªÇп¡ ´ëÇÑ Ã¶ÀúÇÑ Æò°¡¸¦ Á¦°øÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¿¬±¸ °£Ç๰Àº 2025³âºÎÅÍ 2032³â±îÁö ±Û·Î¹ú Ç×ü À§Å¹ Á¦Á¶ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå ±ËÀûÀ» ¼³¸íÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå : ºÐ¼® ¹üÀ§

Ç×ü À§Å¹ Á¦Á¶´Â Ç×ü »ý»êÀ» Àü¹® À§Å¹ °³¹ß ¹× Á¦Á¶ Á¶Á÷(CDMO)¿¡ ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¶Á÷Àº ¾÷½ºÆ®¸² ¹× ´Ù¿î½ºÆ®¸² ó¸®, ºÐ¼® Ư¼ºÈ­, ±ÔÁ¦ Áؼö ¹× ´ë±Ô¸ð »ý»ê¿¡ ´ëÇÑ Àü¹® Áö½ÄÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº Ä¡·á ¹× Áø´Ü ¾ÖÇø®ÄÉÀ̼ÇÀ» À§ÇÑ ´ÜÀÏ Å¬·Ð ¹× ´ÙŬ·Ð Ç×ü °³¹ß¿¡ °ü¿©ÇÏ´Â Á¦¾à ȸ»ç, »ý¸í°øÇРȸ»ç ¹× ¿¬±¸ ±â°üÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀº »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹ÙÀÌ¿À ÇÁ·Î¼¼½Ì ±â¼úÀÇ ¹ßÀü, È¿À²¼º°ú ºñ¿ë È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ ¾Æ¿ô¼Ò½ÌÀÇ Áõ°¡ Ãß¼¼¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°èÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀåÀº ¾Ï, ÀÚ°¡ ¸é¿ª Áúȯ ¹× Àü¿°º´ Ä¡·á¿¡¼­ ´ÜÀÏ Å¬·Ð Ç×ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ºñ·ÔÇÑ ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀǾàǰ°ú Ç¥Àû Ä¡·áÁ¦·ÎÀÇ ÀüȯÀº Àü¹®È­µÈ Ç×ü »ý»ê ´É·Â¿¡ ´ëÇÑ Çʿ伺À» ´õ¿í ÃËÁøÇß½À´Ï´Ù. ÀÏȸ¿ë ¹ÙÀÌ¿À¸®¾×ÅÍ, ¿¬¼Ó ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì, °í󸮷® ½ºÅ©¸®´× ±â¼úÀÇ ¹ßÀüÀ¸·Î Á¦Á¶ È¿À²¼º°ú È®À强ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿ÀÅ×Å© ½ºÅ¸Æ®¾÷ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÚü »ý»ê ºñ¿ëÀÌ ³ô¾ÆÁü¿¡ µû¶ó Ç×ü Á¦Á¶¸¦ CDMO¿¡ ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀ» ¼±È£ÇÏ°Ô µÇ¾ú½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí Ç×ü À§Å¹ Á¦Á¶ ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ³ôÀº »ý»ê ºñ¿ë, ÁöÀû Àç»ê±Ç ¹®Á¦¿Í °°Àº µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ Á¦Á¶ÀÇ º¹À⼺À¸·Î ÀÎÇØ GMP(¿ì¼ö ÀǾàǰ Á¦Á¶ °ü¸® ±âÁØ) Ç¥ÁØÀ» ÁؼöÇØ¾ß ÇϹǷΠ½ÂÀÎ ±â°£ÀÌ ±æ¾îÁö°í ¿î¿µ ºñ¿ëÀÌ ³ô¾ÆÁý´Ï´Ù. ¶ÇÇÑ Ç°Áú °ü¸®, ¿À¿° À§Çè, °ø±Þ¸Á Áߴܰú °ü·ÃµÈ ¿ì·Á·Î ÀÎÇØ À§Å¹ Á¦Á¶¾÷ü´Â ¾î·Á¿òÀ» °Þ½À´Ï´Ù. ¼÷·ÃµÈ ÀηÂÀÇ Á¦ÇÑÀûÀÎ °¡¿ë¼º°ú ½ÅÈï ½ÃÀåÀÇ ÀÎÇÁ¶ó Á¦¾àÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÀúÇØÇÕ´Ï´Ù.

½ÃÀå ±âȸ

Ç×ü À§Å¹ Á¦Á¶ ½ÃÀåÀº ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Ã¤Åà Áõ°¡, CDMO ¿ª·® È®´ë, ¹ÙÀÌ¿À »ý»ê ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ »ó´çÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Ç×ü-¾à¹° Á¢ÇÕü(ADC)¿Í ÀÌÁß Æ¯ÀÌÀû Ç×ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó À§Å¹ Á¦Á¶¾÷ü¿¡ ¼öÀͼºÀÌ ³ôÀº Àü¸ÁÀÌ Á¦½ÃµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿À ÇÁ·Î¼¼½Ì¿¡ ÀΰøÁö´É(AI)°ú ÀÚµ¿È­¸¦ ÅëÇÕÇÏ¸é »ý»ê È¿À²¼ºÀÌ Çâ»óµÇ°í ½ÃÀå Ãâ½Ã ½Ã°£ÀÌ ´ÜÃàµË´Ï´Ù. ¹ÙÀÌ¿ÀÁ¦¾à ±â¾÷°ú CDMO °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê, ÀμöÇÕº´Àº ½ÃÀå ¼ºÀåÀ» À§ÇÑ »õ·Î¿î ±æÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾Æ ÅÂÆò¾ç ¹× ¶óƾ ¾Æ¸Þ¸®Ä« µî ½ÅÈï Áö¿ªÀ¸·Î CDMO ¼­ºñ½º¸¦ È®´ëÇÏ¸é ½ÃÀå ħÅõ·ÂÀÌ ´õ¿í °­È­µÉ °ÍÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ºÎ°¡°¡Ä¡ ÅëÂû

Á¦4Àå ¼¼°èÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦5Àå ¼¼°èÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á : Áö¿ªº°

Á¦6Àå ºÏ¹ÌÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç×ü À§Å¹ Á¦Á¶ ½ÃÀå Àü¸Á

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the global antibodies contract manufacturing market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global antibodies contract manufacturing market from 2025 to 2032.

Key Insights:

Antibodies Contract Manufacturing Market -

Report Scope:

Antibodies contract manufacturing involves the outsourcing of antibody production to specialized contract development and manufacturing organizations (CDMOs). These organizations provide expertise in upstream and downstream processing, analytical characterization, regulatory compliance, and large-scale production. The market caters to pharmaceutical companies, biotechnology firms, and research institutions engaged in the development of monoclonal and polyclonal antibodies for therapeutic and diagnostic applications. Market growth is driven by increasing demand for biologics, advancements in bioprocessing technologies, and the rising trend of outsourcing to enhance efficiency and cost-effectiveness.

Market Growth Drivers:

The global antibodies contract manufacturing market is propelled by several key factors, including the growing demand for monoclonal antibodies in treating cancer, autoimmune diseases, and infectious diseases. The shift towards personalized medicine and targeted therapies has further fueled the need for specialized antibody production capabilities. Advancements in single-use bioreactors, continuous bioprocessing, and high-throughput screening technologies have enhanced manufacturing efficiency and scalability. Additionally, the increasing number of biotech startups, coupled with the high costs of in-house production, has driven the preference for outsourcing antibody manufacturing to CDMOs.

Market Restraints:

Despite promising growth prospects, the antibodies contract manufacturing market faces challenges such as stringent regulatory requirements, high production costs, and intellectual property concerns. The complexity of biologics manufacturing necessitates compliance with Good Manufacturing Practice (GMP) standards, leading to longer approval timelines and higher operational costs. Additionally, concerns related to quality control, contamination risks, and supply chain disruptions pose challenges for contract manufacturers. Limited availability of skilled workforce and infrastructure constraints in emerging markets further hinder market expansion.

Market Opportunities:

The antibodies contract manufacturing market presents significant growth opportunities driven by the increasing adoption of biosimilars, expansion of CDMO capabilities, and technological innovations in bioproduction. The growing demand for antibody-drug conjugates (ADCs) and bispecific antibodies offers lucrative prospects for contract manufacturers. Moreover, the integration of artificial intelligence (AI) and automation in bioprocessing enhances production efficiency and reduces time-to-market. Strategic partnerships, mergers, and acquisitions among biopharma companies and CDMOs are expected to create new avenues for market growth. Expanding CDMO services to emerging regions, such as Asia-Pacific and Latin America, further enhances market penetration.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global antibodies contract manufacturing market, including Lonza Group, Samsung Biologics, and WuXi Biologics, focus on expanding production capacities, technological advancements, and strategic collaborations to gain a competitive edge. These companies invest in state-of-the-art biomanufacturing facilities, continuous bioprocessing, and quality control measures to ensure regulatory compliance and high product quality. Collaborations with pharmaceutical firms, biotechnology startups, and research organizations drive market expansion and facilitate innovation in antibody production. Additionally, emphasis on flexible manufacturing solutions, personalized medicine, and biosimilar development contributes to the evolving landscape of contract antibody manufacturing.

Key Companies Profiled:

Key Segments Covered in Antibody Contract Manufacturing Market Segmentation

By Product:

By Expression System:

By Company Size:

By Scale of Operation:

By Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Value Added Insights

4. Global Antibodies Contract Manufacturing Market Outlook

5. Global Antibodies Contract Manufacturing Market Outlook: Region

6. North America Antibodies Contract Manufacturing Market Outlook

7. Europe Antibodies Contract Manufacturing Market Outlook

8. East Asia Antibodies Contract Manufacturing Market Outlook

9. South Asia & Oceania Antibodies Contract Manufacturing Market Outlook

10. Latin America Antibodies Contract Manufacturing Market Outlook

11. Middle East & Africa Antibodies Contract Manufacturing Market Outlook

12. Competition Landscape

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â